Active CCAAT/Enhancer Binding Protein Gamma (CEBPg) Homo sapiens (Human) Active protein

CEBP-G; GPE1BP; IG/EBP-1

Add to Cart Distributors
Overview
Properties
  • Buffer FormulationPBS, pH7.4, containing 0.01% SKL, 5% Trehalose.
  • Traits Freeze-dried powder, Purity > 95%
  • Isoelectric Point9.9
Share your citation Upload your experimental result Review Leave a message
Loading...

Share a new citation as an author

Upload your experimental result

Review

Please attach serial No. on instruction manual

Contact us

Please fill in the blank.

Name*
Organization
Address
E-mail address*
Telephone
Inquiry*
Verification code* CheckCode
  • Active CCAAT/Enhancer Binding Protein Gamma (CEBPg) Packages (Simulation)
  • Active CCAAT/Enhancer Binding Protein Gamma (CEBPg) Packages (Simulation)
  • APA674Hu01.jpg Figure. SDS-PAGE
  • Certificate ISO9001: 2008, ISO13485: 2003 Registered

Activity test

CCAAT/Enhancer Binding Protein Gamma (CEBPg), a member of the C/EBP family of basic leucine zipper transcription factors, is encoded by the CEBPG gene in humans and widely expressed in various tissues and cell types. It regulates gene transcription by binding to CCAAT/enhancer elements in promoter regions, participating in multiple cellular processes including cell proliferation, differentiation, metabolism and immune response. CEBPg also forms homo- or heterodimers with other C/EBP family members, and its dysregulation is associated with the pathogenesis of several diseases such as cancer and inflammatory disorders. Notably, CEBPg physically interacts with ATF4, a stress-responsive transcription factor, to form functional heterodimers that modulate the expression of target genes under cellular stress.To detect the activity of recombinant human CEBPg, a functional ELISA assay was performed to evaluate the interaction between recombinant human CEBPg and recombinant human ATF4. Briefly, biotin-linked CEBPg were diluted serially in PBS, with 0.01% BSA (pH 7.4). Duplicate samples of 100µl were then transferred to ATF4-coated microtiter wells and incubated for 1h at 37℃. Wells were washed with PBST 3 times and incubation with Streptavidin-HRP for 30min, then wells were aspirated and washed 5 times. With the addition of substrate solution, wells were incubated 15-25 minutes at 37℃. Finally, add 50µl stop solution to the wells and read at 450nm immediately. The binding activity of human CEBPg and human ATF4 was shown in Figure 1, the EC50 for this effect is 0.202µg/mL.

Usage

Reconstitute in ddH2O to a concentration of 0.5-1.0 mg/mL. Do not vortex.

Storage

Avoid repeated freeze/thaw cycles. Store at 2-8°C for one month. Aliquot and store at -80°C for 12 months.

Stability

The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.

Recommend products